CUTENOX

This brand name is authorized in Nigeria. It is also authorized in Brazil.

Active ingredients

The drug CUTENOX contains one active pharmaceutical ingredient (API):

1	Enoxaparin UNII 8NZ41MIK1O - ENOXAPARIN SODIUM
	Enoxaparin is a LMWH with a mean molecular weight of approximately 4,500 daltons, in which the antithrombotic and anticoagulant activities of standard heparin have been dissociated. The drug substance is the sodium salt and has a high anti-Xa activity.
	Read more about Enoxaparin

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A6-0451	Solution for injection	Cutenox Injection 20 mg/0.2 mL INJ_SOL 20 mg/0.2 mL 0.2 mL x 1's (in Pre-Filled Syringe)	Solution for injection in ready-to-use pre-filled syringe. Each 0.2 mL pre-filled syringe contains: Enoxaparin Sodium USP 20 mg (100 mg/mL)	03/07/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
B01AB05	Enoxaparin	B Blood and blood forming organs → B01 Antithrombotic agents → B01A Antithrombotic agents → B01AB Heparin group
Discover more medicines within B01AB05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	541517070004017, 541517070004117, 541517070004217, 541517070004317, 541517070004417, 541517070004517, 541517070004617, 541517070004717, 541517070004817, 541517070004917, 541517070005017, 541517070005117
NG	Registered Drug Product Database	A6-0451